CoChat

Presenilin 1 deficiency suppresses autophagy in human neural stem cells through reducing γ-secretase-independent ERK/CREB signaling

Open access

The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.

Abstract

Autophagy impairment is commonly implicated in the pathological characteristic of Alzheimer’s disease (AD). Presenilin 1 (PS1) expression in human brain gradually decreases with age and its mutations account for the most common cases of early-onset familial Alzheimer’s disease (FAD). The dominant autophagy phenotypes occur in PS1-knockout and PS1 mutant neurons; it is still unknown whether PS1 deficiency causes serious autophagy impairment in neural stem cells (NSCs). Herein, we generated the heterozygote and homozygote of PS1 knockout in human induced pluripotent stem cells (iPSCs) via CRISPR/Cas9-based gene editing and differentiated them into human NSCs. In these human PS1-deficient NSCs, reduced autophagosome formation and downregulated expression of autophagy–lysosome pathway (ALP)-related mRNAs, as well as proteins were observed. Mechanistically, ERK/CREB inhibition and GSK3β activation had key roles in reducing TFEB expression in PS1-knockout NSCs. Pharmacological inhibition of GSK3β upregulated the expression of TFEB and ALP-related proteins in PS1-knockout NSCs, whereas this effect could be blocked by CREB inhibition. These findings demonstrate that PS1 deficiency causes autophagy suppression in human NSCs via downregulating ERK/CREB signaling.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41419-018-0945-7

Cites

54 of 54 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Characteristics of human iPSC-derived NSCs with PS1 knockout. a SOX2 and Nestin immunostaining of NSCs from iPSC lines and phase-contrast images of neurospheres. b The levels of PS1 mRNA in iPSCs and NSCs were detected by qRT-PCR. c The expression of N-terminal fragment (NTF) and C-terminal fragment (CTF) of PS1 was detected and quantified by western blotting using specific antibodies. Data are represented as mean ± SD. ***P < 0.005 was considered significantly different
Fig. 1 Characteristics of human iPSC-derived NSCs with PS1 knockout. a SOX2 and Nestin immunostaining of NSCs from iPSC lines and phase-contrast images of neurospheres. b The levels of PS1 mRNA in iPSCs and NSCs were detected by qRT-PCR. c The expression of N-terminal fragment (NTF) and C-terminal fragment (CTF) of PS1 was detected and quantified by western blotting using specific antibodies. Data are represented as mean ± SD. ***P < 0.005 was considered significantly differentCC BY · PubMed Central
Fig. 2 PS1 deficiency suppressed Torin 1-induced autophagosome formation and basal autophagy flux in human NSCs. a Western blotting of LC3b and p62 in PS1-knockout NSCs. b Western blotting of LC3b and p62 in PS1-knockout NSCs in the presence Torin 1. Autophagy flux and LC3b-II level were quantified by western blotting. c Representative images and d the number of punctate GFP–LC3 in PS1-knockout NSCs with or without Torin 1 treatment. Sample numbers were n = 50. e Western blotting of LC3b in PS1-knockout NSCs after incubation with CQ for 0, 3, and 6 h. f LC3b-II levels were quantified by western blotting. Beta-actin as internal control. Data are represented as mean ± SD. ***P < 0.005 vs. the PS+/+ group was considered significantly different
Fig. 2 PS1 deficiency suppressed Torin 1-induced autophagosome formation and basal autophagy flux in human NSCs. a Western blotting of LC3b and p62 in PS1-knockout NSCs. b Western blotting of LC3b and p62 in PS1-knockout NSCs in the presence Torin 1. Autophagy flux and LC3b-II level were quantified by western blotting. c Representative images and d the number of punctate GFP–LC3 in PS1-knockout NSCs with or without Torin 1 treatment. Sample numbers were n = 50. e Western blotting of LC3b in PS1-knockout NSCs after incubation with CQ for 0, 3, and 6 h. f LC3b-II levels were quantified by western blotting. Beta-actin as internal control. Data are represented as mean ± SD. ***P < 0.005 vs. the PS+/+ group was considered significantly differentCC BY · PubMed Central
Fig. 3 PS1 deficiency downregulated the expression of autophagy-related genes at transcriptional and translational levels in human NSCs. a qRT-PCR for determining mRNA expression of autophagy-related genes in PS1-knockout NSCs. b The expression of LC3b-1, Atg7, TFEB, Atp6v, pro-cathepsin D, Lamp1, and beta-actin in PS1-knockout NSCs was detected by western blotting with specific antibodies. Data are represented as mean ± SD. *P < 0.05, **P < 0.01, ***P < 0.005 vs. the PS+/+ group were considered significantly different
Fig. 3 PS1 deficiency downregulated the expression of autophagy-related genes at transcriptional and translational levels in human NSCs. a qRT-PCR for determining mRNA expression of autophagy-related genes in PS1-knockout NSCs. b The expression of LC3b-1, Atg7, TFEB, Atp6v, pro-cathepsin D, Lamp1, and beta-actin in PS1-knockout NSCs was detected by western blotting with specific antibodies. Data are represented as mean ± SD. *P < 0.05, **P < 0.01, ***P < 0.005 vs. the PS+/+ group were considered significantly differentCC BY · PubMed Central
Fig. 4 Inhibition of γ-secretase activity did not suppress autophagy in PS1-deficient NSCs. a qRT-PCR for determining mRNA expression of Hes1 in PS1-knockout NSCs. b Hes1 expression were detected and quantified by western blotting. Data are represented as mean ± SD. *P < 0.05, ***P < 0.005 vs. the PS+/+ group were considered significantly different. c Western blotting for determining the expression of LC3b and Hes1 in isogenic PS1+/+ NSCs were treated with 10 μM DAPT for 24 h. DMSO was used as the vehicle control. ***P < 0.005 vs. the control group were considered significantly different. Data are represented as mean ± SD
Fig. 4 Inhibition of γ-secretase activity did not suppress autophagy in PS1-deficient NSCs. a qRT-PCR for determining mRNA expression of Hes1 in PS1-knockout NSCs. b Hes1 expression were detected and quantified by western blotting. Data are represented as mean ± SD. *P < 0.05, ***P < 0.005 vs. the PS+/+ group were considered significantly different. c Western blotting for determining the expression of LC3b and Hes1 in isogenic PS1+/+ NSCs were treated with 10 μM DAPT for 24 h. DMSO was used as the vehicle control. ***P < 0.005 vs. the control group were considered significantly different. Data are represented as mean ± SDCC BY · PubMed Central
Fig. 5 PS1 deficiency-induced autophagy suppression resulted from reduced ERK activity, not reduced Akt activity. a The lysates from PS1+/+, PS1+/−, and PS−/− NSCs were immunoprecipitated with the anti-PI3Kp85 antibody and obtained IPs were analyzed for N-cadherin, PI3Kp85. b The expression of P-PI3Kp85, total PI3Kp85, P-Akt, total Akt, and β-actin in PS1-knockout NSCs were determined by western blotting. c The lysates from PS1+/+, PS1+/−, and PS−/− NSCs were immunoprecipitated with the anti-APP antibody and obtained IPs were analyzed for APP, GRB2. d The expression of P-ERK1/2, total ERK1/2, and β-actin in PS1-knockout NSCs were determined by western blotting. Data are represented as mean ± SD. **P < 0.01, ***P < 0.005 vs. the PS+/+ group were considered significantly different. e Western blotting of indicated proteins in PS1+/+ NSCs with 10 μM Akt inhibitor IV or 10 μM U0126 treatment. f Autophagy flux and LC3b-II level were quantified by western blotting. Data are represented as mean ± SD. ***P < 0.005 vs. the control group was considered significantly different
Fig. 5 PS1 deficiency-induced autophagy suppression resulted from reduced ERK activity, not reduced Akt activity. a The lysates from PS1+/+, PS1+/−, and PS−/− NSCs were immunoprecipitated with the anti-PI3Kp85 antibody and obtained IPs were analyzed for N-cadherin, PI3Kp85. b The expression of P-PI3Kp85, total PI3Kp85, P-Akt, total Akt, and β-actin in PS1-knockout NSCs were determined by western blotting. c The lysates from PS1+/+, PS1+/−, and PS−/− NSCs were immunoprecipitated with the anti-APP antibody and obtained IPs were analyzed for APP, GRB2. d The expression of P-ERK1/2, total ERK1/2, and β-actin in PS1-knockout NSCs were determined by western blotting. Data are represented as mean ± SD. **P < 0.01, ***P < 0.005 vs. the PS+/+ group were considered significantly different. e Western blotting of indicated proteins in PS1+/+ NSCs with 10 μM Akt inhibitor IV or 10 μM U0126 treatment. f Autophagy flux and LC3b-II level were quantified by western blotting. Data are represented as mean ± SD. ***P < 0.005 vs. the control group was considered significantly differentCC BY · PubMed Central
Fig. 6 GSK3β inhibition upregulated the expression of autophagy proteins in PS1-knockout NSCs. a The expression of P-GSK3β and total GSK3β in PS1-knockout NSCs were determined by western blotting. b The levels of nuclear GSK3β in PS1-knockout NSCs were evaluated by western blotting. Data are represented as mean ± SD. *P < 0.05, **P < 0.01, ***P < 0.005 vs. the PS1+/+ group was considered significantly different. c The expression of TFEB in PS1+/+ NSCs expressing GSK3β (WT), GSK3β (KD), or GSK3β (CA) was determined by western blotting. ***P < 0.005 vs. the GSK3β (WT) group was considered significantly different. d qRT-PCR for determining mRNA expression of autophagy-related genes in PS1−/− NSCs treated with 10 μM SB212763 for 4 h. DMSO was used as the vehicle control. e After NSCs were treated with 10 μM SB212763 for 24 h, the expression of TFEB, Lamp1, LC3b-I, and β-actin in PS1−/− NSCs was determined by western blotting with specific antibodies. Data are represented as mean ± SD. *P < 0.05, **P < 0.01, ***P < 0.005 vs. the control group was considered significantly different. f A proposed mechanism of PS1 deficiency-induced GSK3β nuclear translocation to block the expression of autophagy genes
Fig. 6 GSK3β inhibition upregulated the expression of autophagy proteins in PS1-knockout NSCs. a The expression of P-GSK3β and total GSK3β in PS1-knockout NSCs were determined by western blotting. b The levels of nuclear GSK3β in PS1-knockout NSCs were evaluated by western blotting. Data are represented as mean ± SD. *P < 0.05, **P < 0.01, ***P < 0.005 vs. the PS1+/+ group was considered significantly different. c The expression of TFEB in PS1+/+ NSCs expressing GSK3β (WT), GSK3β (KD), or GSK3β (CA) was determined by western blotting. ***P < 0.005 vs. the GSK3β (WT) group was considered significantly different. d qRT-PCR for determining mRNA expression of autophagy-related genes in PS1−/− NSCs treated with 10 μM SB212763 for 4 h. DMSO was used as the vehicle control. e After NSCs were treated with 10 μM SB212763 for 24 h, the expression of TFEB, Lamp1, LC3b-I, and β-actin in PS1−/− NSCs was determined by western blotting with specific antibodies. Data are represented as mean ± SD. *P < 0.05, **P < 0.01, ***P < 0.005 vs. the control group was considered significantly different. f A proposed mechanism of PS1 deficiency-induced GSK3β nuclear translocation to block the expression of autophagy genesCC BY · PubMed Central
Fig. 7 CREB inhibitor blocked the effect of GSK3β in PS1-knockout NSCs. a The expression of CREB and Bcl2 in PS1-knockout NSCs were determined by western blotting. Data are represented as mean ± SD. *P < 0.05, **P < 0.01, ***P < 0.005 vs. the PS1+/+ group was considered significantly different. b qRT-PCR for determining mRNA expression of Bcl2 in PS1−/− NSCs treated with 10 μM SB212763 for 4 h. DMSO was used as the vehicle control. Data are represented as mean ± SD. ***P < 0.005 vs. the control group was considered significantly different. c The effect of CREB inhibitor on TFEB expression in PS+/+ NSCs was determined by western blotting. Data are represented as mean ± SD. **P < 0.01, ***P < 0.005 vs. the control group was considered significantly different. d PS−/− NSCs were treated with 10 μM SB216763 or 2 μM CREB inhibitor or both for 24 h. The expression of TFEB and beta-action were determined by western blotting. Data are represented as mean ± SD. ***P < 0.005 vs. control group was considered significantly different. e A proposed mechanism of PS1 deficiency-induced autophagy suppression through the reduced ERK signaling
Fig. 7 CREB inhibitor blocked the effect of GSK3β in PS1-knockout NSCs. a The expression of CREB and Bcl2 in PS1-knockout NSCs were determined by western blotting. Data are represented as mean ± SD. *P < 0.05, **P < 0.01, ***P < 0.005 vs. the PS1+/+ group was considered significantly different. b qRT-PCR for determining mRNA expression of Bcl2 in PS1−/− NSCs treated with 10 μM SB212763 for 4 h. DMSO was used as the vehicle control. Data are represented as mean ± SD. ***P < 0.005 vs. the control group was considered significantly different. c The effect of CREB inhibitor on TFEB expression in PS+/+ NSCs was determined by western blotting. Data are represented as mean ± SD. **P < 0.01, ***P < 0.005 vs. the control group was considered significantly different. d PS−/− NSCs were treated with 10 μM SB216763 or 2 μM CREB inhibitor or both for 24 h. The expression of TFEB and beta-action were determined by western blotting. Data are represented as mean ± SD. ***P < 0.005 vs. control group was considered significantly different. e A proposed mechanism of PS1 deficiency-induced autophagy suppression through the reduced ERK signalingCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 54 references

Cited by

See all 66

Metadata

Authors
Chong, C.-M., Ke, M., Tan, Y., Huang, Z., Zhang, K., Ai, N., Ge, W., Qin, D., Lu, J.-H., & Su, H.
Affiliations
  • University of Macau (MO)
  • Chinese Academy of Sciences (CN)
Corresponding author
  • Qin, Dajiang
  • Su, Huanxing
Venue
Cell Death & Disease
Published
2018-08-29
Volume
9
Issue
9
Pages
879-879
ISSN
2041-4889 (ISSN-L)
OpenAlex
W2889487737
Cited by
66
References
54
Citations by year
2026: 5 · 2025: 12 · 2024: 4 · 2023: 7 · 2022: 10 · 2021: 10 · 2020: 11 · 2019: 7
FWCI
5.47
Type
journal article
Language
en
Open access
Licence
Locations
  • Cell Death and Disease (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • National Natural Science Foundation of China (2015B020225001, 2016YFA0100801)
  • Chinese Academy of Sciences (154144KYSB20160059)
  • Universidade de Macau (MYRG2016‐00184‐ICMS‐QRCM)
  • Fundo para o Desenvolvimento das Ciências e da Tecnologia (020/2017/A1, 039/2017/AFJ)
  • Science and Technology Planning Project of Guangdong Province (2014B050502012, 154144KYSB20160059)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Calcium signaling and nucleotide metabolism
Keywords
presenilin 1, autophagy, neural stem cells, Alzheimer's disease, ERK/CREB signaling, GSK3β, TFEB, autophagy-lysosome pathway, induced pluripotent stem cells, CRISPR/Cas9 genome editing, autophagosome formation
MeSH terms
Autophagosomes, Glycogen Synthase Kinase 3 beta, Alzheimer Disease, Autophagy, Brain, Cells, Cultured, Humans, Lysosomes, Mutation, Neurons, RNA, Messenger, Signal Transduction, Down-Regulation, Up-Regulation, Cyclic AMP Response Element-Binding Protein, MAP Kinase Signaling System, Presenilin-1, Amyloid Precursor Protein Secretases, Induced Pluripotent Stem Cells, Neural Stem Cells, CRISPR-Cas Systems

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Presenilin 1 deficiency suppresses autophagy in human neural stem cells through reducing γ-secretase-independent ERK/CREB signaling. https://app.cochat.ai/papers/10.1038/s41419-018-0945-7
The paper
Chong, C.-M., Ke, M., Tan, Y., Huang, Z., Zhang, K., Ai, N., Ge, W., Qin, D., Lu, J.-H., & Su, H. (2018). Presenilin 1 deficiency suppresses autophagy in human neural stem cells through reducing γ-secretase-independent ERK/CREB signaling. Cell Death & Disease. https://doi.org/10.1038/s41419-018-0945-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.